Cardia-cerebrovascular Disease
Conditions
Interventions
experimental group:Oral calcium or vitamin D supplement
Control group:Blank control
Sponsors
The First Affiliated Hospital of Bengbu Medical College
Eligibility
Sex/Gender
All
Age
55 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. The age of starting calcium and vitamin D supplements is =55 years old; 2. The total time of continuous use or intermittent use of calcium supplements (with or without vitamin D) is =2 years; 3. It can cooperate with relevant laboratories, Imaging examination and cognitive emotional function survey.
Exclusion criteria
Exclusion criteria: 1. Calcium and vitamin D supplements have occurred before the use of cardiovascular and cerebrovascular diseases, including myocardial infarction, coronary heart disease, ischemic heart disease, cerebral infarction, cerebral hemorrhage, vascular dementia and peripheral vascular disease; 2. People with congenital heart disease, rheumatic heart disease, hypertrophic heart disease, dilated heart disease; 3. People with moyamoya disease, hereditary cerebrovascular disease; 4. Congenital abdominal aorta, renal artery , peripheral arterial stenosis or deformity; 5. People with parathyroid diseases, such as hypoparathyroidism, hyperparathyroidism, etc.; 6 are unwilling to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Carotid intima-media thickness;Aortic calcification;Cerebral stenosis;Cardia-cerebrovascular Disease mortality; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood glucose;Blood lipid examination;Blood lipid examination;liver function;renal function; | — |
Countries
China
Contacts
Public ContactHuadong Zhou
Outcome results
None listed